| Literature DB >> 35400141 |
Rishi Trikha1, Grant G Schroeder2, Danielle E Greig1, Thomas J Kremen1.
Abstract
Background: There is limited literature characterizing the incidence, variety, and effects of injuries and illnesses observed in elite swimmers. Purpose: To describe the epidemiology of injuries and illnesses affecting elite intercollegiate competitive swimmers. Study Design: Descriptive epidemiology study.Entities:
Keywords: illness; injuries; return to sport; swimming
Year: 2022 PMID: 35400141 PMCID: PMC8988675 DOI: 10.1177/23259671221083588
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Musculoskeletal Injuries by Body Part in Collegiate Swimmers, 2016 to 2020
| Overall (N = 641 Athletes) | Female Athletes (n = 340) | Male Athletes (n = 301) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Events | Athletes Affected | Estimated Athlete Risk/y, % | Events | Athletes Affected | Estimated Athlete Risk/y, % | Events | Athletes Affected | Estimated Athlete Risk/y, % | RR | |
| Shoulder | 126 (23.33) | 101 (15.76) | 6.89 | 81 (23.41) | 65 (19.12) | 8.36 | 45 (23.2) | 36 (11.96) | 5.23 | 1.6 |
| Spine | 95 (17.59) | 84 (13.1) | 5.73 | 67 (19.36) | 56 (16.47) | 7.21 | 28 (14.43) | 28 (9.3) | 4.07 | 1.77 |
| Foot/ankle/lower leg | 81 (15) | 75 (11.7) | 5.12 | 55 (15.9) | 50 (14.71) | 6.43 | 26 (13.4) | 25 (8.31) | 3.63 | 1.77 |
| Knee/thigh | 67 (12.41) | 56 (8.74) | 3.82 | 39 (11.27) | 33 (9.71) | 4.25 | 28 (14.43) | 23 (7.64) | 3.34 | 1.27 |
| Hand/wrist/forearm | 52 (9.63) | 50 (7.8) | 3.41 | 28 (8.09) | 26 (7.65) | 3.35 | 24 (12.37) | 24 (7.97) | 3.49 | 0.96 |
| Groin/hip/pelvis/buttock | 46 (8.52) | 44 (6.86) | 3.00 | 30 (8.67) | 29 (8.53) | 3.73 | 16 (8.25) | 15 (4.98) | 2.18 | 1.71 |
| Elbow/upper arm | 26 (4.81) | 25 (3.9) | 1.71 | 18 (5.2) | 17 (5) | 2.19 | 8 (4.12) | 8 (2.66) | 1.16 | 1.88 |
| Chest/abdomen | 26 (4.81) | 26 (4.06) | 1.77 | 14 (4.05) | 14 (4.12) | 1.80 | 12 (6.19) | 12 (3.99) | 1.74 | 1.03 |
| Head/face/neck | 16 (2.96) | 16 (2.5) | 1.09 | 13 (3.76) | 13 (3.82) | 1.67 | 3 (1.55) | 3 (1) | 0.44 | 3.84 |
| Unclassified | 5 (0.93) | 5 (0.78) | 0.34 | 1 (0.29) | 1 (0.29) | 0.13 | 4 (2.06) | 4 (1.33) | 0.58 | 0.22 |
| Total | 540 (100) | 253 (39.47) | 17.27 | 346 (100) | 159 (46.76) | 20.46 | 194 (100) | 94 (31.23) | 13.66 | 1.5 |
Data are reported as n (%) unless otherwise indicated.
Relative risk, female vs male.
Statistical significance (P < .05).
Excludes concussions.
Nonmusculoskeletal Illnesses in Collegiate Swimmers, 2016 to 2020
| Overall (N = 641 Athletes) | Female Athletes (n = 340) | Male Athletes (n = 301) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Events | Athletes Affected | Estimated Athlete Risk/y, % | Events | Athletes Affected | Estimated Athlete Risk/y, % | Events | Athletes Affected | Estimated Athlete Risk/y, % | RR | |
| Respiratory tract infection | 119 (24.29) | 79 (12.32) | 5.39 | 62 (21.45) | 49 (14.41) | 6.31 | 57 (28.36) | 30 (9.97) | 4.36 | 1.45 |
| Unspecified medical illness | 93 (18.98) | 52 (8.11) | 3.55 | 45 (15.57) | 23 (6.76) | 2.96 | 48 (23.88) | 29 (9.63) | 4.22 | 0.7 |
| Concussion | 58 (11.84) | 44 (6.86) | 3.00 | 43 (14.88) | 31 (9.12) | 3.99 | 15 (7.46) | 13 (4.32) | 1.89 | 2.11 |
| Ear infection | 25 (5.1) | 21 (3.28) | 1.43 | 15 (5.19) | 13 (3.82) | 1.67 | 10 (4.98) | 8 (2.66) | 1.16 | 1.44 |
| Gastrointestinal illness | 24 (4.9) | 24 (3.74) | 1.64 | 15 (5.19) | 15 (4.41) | 1.93 | 9 (4.48) | 9 (2.99) | 1.31 | 1.48 |
| Influenza | 22 (4.49) | 21 (3.28) | 1.43 | 11 (3.81) | 10 (2.94) | 1.29 | 11 (5.47) | 11 (3.65) | 1.60 | 0.8 |
| Sinusitis | 17 (3.47) | 17 (2.65) | 1.16 | 7 (2.42) | 7 (2.06) | 0.90 | 10 (4.98) | 10 (3.32) | 1.45 | 0.62 |
| Dermatological illness | 13 (2.65) | 13 (2.03) | 0.89 | 9 (3.11) | 9 (2.65) | 1.16 | 4 (1.99) | 4 (1.33) | 0.58 | 1.99 |
| Eye infection | 12 (2.45) | 12 (1.87) | 0.82 | 8 (2.77) | 8 (2.35) | 1.03 | 4 (1.99) | 4 (1.33) | 0.58 | 1.77 |
| Head injury | 12 (2.45) | 12 (1.87) | 0.82 | 7 (2.42) | 7 (2.06) | 0.90 | 5 (2.49) | 5 (1.66) | 0.73 | 1.24 |
| Mononucleosis | 11 (2.24) | 11 (1.72) | 0.75 | 7 (2.42) | 7 (2.06) | 0.90 | 4 (1.99) | 4 (1.33) | 0.58 | 1.55 |
| Pharyngitis | 10 (2.04) | 8 (1.25) | 0.55 | 8 (2.77) | 6 (1.76) | 0.77 | 2 (1) | 2 (0.66) | 0.29 | 2.66 |
| Systemic viral infection | 10 (2.04) | 8 (1.25) | 0.55 | 7 (2.42) | 5 (1.47) | 0.64 | 3 (1.49) | 3 (1) | 0.44 | 1.48 |
| No diagnosis provided | 10 (2.04) | 10 (1.56) | 0.68 | 9 (3.11) | 9 (2.65) | 1.16 | 1 (0.5) | 1 (0.33) | 0.15 | 7.97 |
| Mental health event | 9 (1.84) | 9 (1.4) | 0.61 | 7 (2.42) | 7 (2.06) | 0.90 | 2 (1) | 2 (0.66) | 0.29 | 3.1 |
| Skin or soft tissue infection | 9 (1.84) | 8 (1.25) | 0.55 | 7 (2.42) | 6 (1.76) | 0.77 | 2 (1) | 2 (0.66) | 0.29 | 2.66 |
| Respiratory disease | 8 (1.63) | 8 (1.25) | 0.55 | 5 (1.73) | 5 (1.47) | 0.64 | 3 (1.49) | 3 (1) | 0.44 | 1.48 |
| Headache | 7 (1.43) | 6 (0.94) | 0.41 | 6 (2.08) | 5 (1.47) | 0.64 | 1 (0.5) | 1 (0.33) | 0.15 | 4.43 |
| Cardiovascular illness | 6 (1.22) | 6 (0.94) | 0.41 | 2 (0.69) | 2 (0.59) | 0.26 | 4 (1.99) | 4 (1.33) | 0.58 | 0.44 |
| Pneumonia | 6 (1.22) | 5 (0.78) | 0.34 | 4 (1.38) | 3 (0.88) | 0.39 | 2 (1) | 2 (0.66) | 0.29 | 1.33 |
| Allergic reaction | 5 (1.02) | 5 (0.78) | 0.34 | 3 (1.04) | 3 (0.88) | 0.39 | 2 (1) | 2 (0.66) | 0.29 | 1.33 |
| Bronchitis | 4 (0.82) | 4 (0.62) | 0.27 | 2 (0.69) | 2 (0.59) | 0.26 | 2 (1) | 2 (0.66) | 0.29 | 0.89 |
| Total | 490 (100) | 197 (30.73) | 13.45 | 289 (100) | 118 (34.71) | 15.18 | 201 (100) | 79 (26.25) | 11.48 | 1.32 |
Data are reported as n (%) unless otherwise indicated.
Relative risk, female vs male.
Detailed data to determine what kind of medical illness unavailable.
Statistical significance (P < .05).
Top 5 Musculoskeletal Injuries and Nonmusculoskeletal Illnesses Among Elite Versus Nonelite Athletes
| Events | Athletes Affected | Estimated Athlete Risk/y, % | Events | Athletes Affected | Estimated Athlete Risk/y, % | ||
|---|---|---|---|---|---|---|---|
| Female Elite Athletes (n = 59) | Female Nonelite Athletes (n = 87) | RR (95% CI) | |||||
| Top 5 musculoskeletal injuries | |||||||
| Lumbar strain | 7 (3.98) | 5 (8.47) | 3.71 | 12 (4.03) | 9 (10.34) | 4.53 | 0.82 (0.29-2.32) |
| Lateral ankle sprain | 7 (3.98) | 6 (10.17) | 4.45 | 8 (2.68) | 7 (8.05) | 3.52 | 1.26 (0.45-3.57) |
| Shoulder internal impingement | 9 (5.11) | 7 (11.86) | 5.19 | 10 (3.36) | 8 (9.2) | 4.02 | 1.29 (0.49-3.37) |
| Biceps tendinopathy | 0 (0) | 0 (0) | 0.00 | 2 (0.67) | 2 (2.3) | 1.01 | — |
| Shoulder tendon overuse injury | 4 (2.27) | 3 (5.08) | 2.22 | 4 (1.34) | 2 (2.3) | 1.01 | 2.21 (0.38-12.84) |
| Top 5 nonmusculoskeletal illnesses | |||||||
| Respiratory tract infection | 8 (4.55) | 7 (11.86) | 5.19 | 42 (14.09) | 29 (33.33) | 14.58 | 0.36 (0.17-0.76) |
| Unspecified medical illness | 40 (22.73) | 18 (30.51) | 13.35 | 40 (13.42) | 18 (20.69) | 9.05 | 1.47 (0.84-2.59) |
| Concussion | 10 (5.68) | 5 (8.47) | 3.71 | 13 (4.36) | 8 (9.2) | 4.02 | 0.92 (0.32-2.68) |
| Ear infection | 2 (1.14) | 2 (3.39) | 1.48 | 6 (2.01) | 5 (5.75) | 2.51 | 0.59 (0.12-2.94) |
| Gastrointestinal illness | 2 (1.14) | 2 (3.39) | 1.48 | 8 (2.68) | 8 (9.2) | 4.02 | 0.37 (0.08-1.68) |
| Male Elite Athletes (n = 68) | Male Nonelite Athletes (n = 95) | ||||||
| Top 5 musculoskeletal injuries | |||||||
| Lumbar strain | 1 (0.64) | 1 (1.47) | 0.64 | 2 (0.75) | 2 (2.11) | 0.92 | 0.7 (0.06-7.55) |
| Lateral ankle sprain | 2 (1.28) | 2 (2.94) | 1.29 | 2 (0.75) | 2 (2.11) | 0.92 | 1.4 (0.2-9.67) |
| Shoulder internal impingement | 4 (2.56) | 3 (4.41) | 1.93 | 7 (2.62) | 5 (5.26) | 2.30 | 0.84 (0.21-3.39) |
| Biceps tendinopathy | 1 (0.64) | 1 (1.47) | 0.64 | 5 (1.87) | 5 (5.26) | 2.30 | 0.28 (0.03-2.34) |
| Shoulder tendon overuse injury | 1 (0.64) | 1 (1.47) | 0.64 | 2 (0.75) | 2 (2.11) | 0.92 | 0.7 (0.06-7.55) |
| Top 5 nonmusculoskeletal illnesses | |||||||
| Respiratory tract infection | 9 (5.77) | 5 (7.35) | 3.22 | 47 (17.6) | 20 (21.05) | 9.21 | 0.35 (0.14-0.88) |
| Unspecified medical illness | 40 (25.64) | 21 (30.88) | 13.51 | 41 (15.36) | 22 (23.16) | 10.13 | 1.33 (0.8-2.22) |
| Concussion | 2 (1.28) | 2 (2.94) | 1.29 | 5 (1.87) | 5 (5.26) | 2.30 | 0.56 (0.11-2.8) |
| Ear infection | 2 (1.28) | 2 (2.94) | 1.29 | 7 (2.62) | 5 (5.26) | 2.30 | 0.56 (0.11-2.8) |
| Gastrointestinal illness | 1 (0.64) | 1 (1.47) | 0.64 | 3 (1.12) | 3 (3.16) | 1.38 | 0.47 (0.05-4.38) |
Data are reported as n (%) unless otherwise indicated.
Relative risk, elite vs nonelite.
Statistical significance (P < .05).
Detailed data to determine what kind of medical illness unavailable.
Return-to-Sport Data for Most Common Diagnoses for Musculoskeletal Injuries and Nonmusculoskeletal Illnesses
| Did Not Miss Time | Missed Time but Returned to Sport in the Same Season | Season-Ending but Not Career-Ending Injury | Career-Ending Injury | Not Specified or Athlete Left Campus | Total, n | |
|---|---|---|---|---|---|---|
| Top 5 musculoskeletal injuries | ||||||
| Lumbar strain | 21 (61.8) | 11 (32.4) | 2 (5.9) | 0 (0) | 0 (0) | 34 |
| Lateral ankle sprain | 11 (44.0) | 12 (48.0) | 1 (4.0) | 0 (0) | 1 (4.0) | 25 |
| Shoulder internal impingement | 14 (66.7) | 7 (33.3) | 0 (0) | 0 (0) | 0 (0) | 21 |
| Biceps tendinopathy | 14 (77.8) | 2 (11.1) | 1 (5.6) | 1 (5.6) | 0 (0) | 18 |
| Shoulder tendon overuse injury | 8 (61.5) | 4 (30.8) | 1 (7.7) | 0 (0) | 0 (0) | 13 |
| Top 5 nonmusculoskeletal illnesses | ||||||
| Respiratory tract infection | 75 (63.0) | 41 (34.5) | 0 (0) | 1 (0.8) | 2 (1.7) | 119 |
| Unspecified medical illness | 31 (36.5) | 37 (43.5) | 1 (1.2) | 14 (16.5) | 2 (2.4) | 85 |
| Concussion | 0 (0) | 34 (58.6) | 8 (13.8) | 14 (24.1) | 2 (3.4) | 58 |
| Ear infection | 22 (88.0) | 3 (12.0) | 0 (0) | 0 (0) | 0 (0) | 25 |
| Gastrointestinal illness | 10 (50.0) | 10 (50.0) | 0 (0) | 0 (0) | 0 (0) | 20 |
Data are reported as n (%) unless otherwise indicated.
Detailed data to determine what kind of medical illness unavailable.
Return-to-Sport Data for Most Common Musculoskeletal Injuries, Stratified by Body Part
| Shoulder | Spine | Foot/Ankle/ | Knee/Thigh | Hand/Wrist/ | Groin/Hip/ | |
|---|---|---|---|---|---|---|
| Men | ||||||
| Did not miss time | 33 (73.3) | 15 (53.6) | 18 (69.2) | 14 (50.0) | 11 (45.8) | 11 (68.8) |
| Missed time but returned to sport in same season | 11 (24.4) | 14 (50.0) | 7 (26.9) | 11 (39.3) | 11 (45.8) | 5 (31.3) |
| Season-ending but not career-ending | 1 (2.2) | 0 (0) | 1 (3.8) | 0 (0) | 0 (0) | 0 (0) |
| Career-ending | 0 (0) | 1 (3.6) | 0 (0) | 3 (10.7) | 2 (8.3) | 0 (0) |
| Total, n | 45 | 28 | 26 | 28 | 24 | 16 |
| Women | ||||||
| Did not miss time | 52 (64.2) | 36 (53.7) | 35 (63.6) | 26 (66.7) | 19 (67.9) | 11 (36.7) |
| Missed time but returned to sport in same season | 27 (33.3) | 27 (40.3) | 18 (32.7) | 11 (28.2) | 7 (25.0) | 16 (53.3) |
| Season-ending but not career-ending | 2 (2.5) | 2 (3.0) | 1 (1.8) | 0 (0) | 0 (0) | 1 (3.3) |
| Career-ending | 1 (1.2) | 2 (3.0) | 1 (1.8) | 2 (5.1) | 2 (7.1) | 2 (6.7) |
| Total, n | 81 | 67 | 55 | 39 | 28 | 30 |
Data are reported as n (%) unless otherwise indicated.
Shoulder Injury Characteristics Observed Among Athletes in This Study
| Overall (N = 641) | Female Athletes (n = 340) | Male Athletes (n = 301) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Events | Athletes Affected | Estimated Athlete Risk/y, % | Events | Athletes Affected | Estimated Athlete Risk/y, % | Events | Athletes Affected | Estimated Athlete Risk/y, % | RR | |
| Shoulder internal impingement | 21 (3.89) | 17 (2.65) | 1.16 | 14 (17.28) | 12 (3.53) | 1.54 | 7 (15.56) | 5 (1.66) | 0.73 | 2.12 |
| Biceps tendinopathy | 18 (3.33) | 18 (2.81) | 1.23 | 12 (14.81) | 12 (3.53) | 1.54 | 6 (13.33) | 6 (1.99) | 0.87 | 1.77 |
| Shoulder tendon overuse injury | 13 (2.41) | 13 (2.03) | 0.89 | 8 (9.88) | 8 (2.35) | 1.03 | 5 (11.11) | 5 (1.66) | 0.73 | 1.42 |
| Shoulder muscle strain | 10 (1.85) | 9 (1.4) | 0.61 | 8 (9.88) | 7 (2.06) | 0.90 | 2 (4.44) | 2 (0.66) | 0.29 | 3.1 |
| Subacromial impingement | 9 (1.67) | 8 (1.25) | 0.55 | 9 (11.11) | 8 (2.35) | 1.03 | 0 (0) | 0 (0) | 0.00 | — |
| Chronic shoulder instability | 9 (1.67) | 9 (1.4) | 0.61 | 6 (7.41) | 6 (1.76) | 0.77 | 3 (6.67) | 3 (1) | 0.44 | 1.77 |
| Acute shoulder sprain/subluxation | 6 (1.11) | 6 (0.94) | 0.41 | 2 (2.47) | 2 (0.59) | 0.26 | 4 (8.89) | 4 (1.33) | 0.58 | 0.44 |
| Shoulder synovitis | 5 (0.93) | 5 (0.78) | 0.34 | 4 (4.94) | 4 (1.18) | 0.51 | 1 (2.22) | 1 (0.33) | 0.15 | 3.54 |
| Pectoralis major muscle injury | 4 (0.74) | 4 (0.62) | 0.27 | 3 (3.7) | 3 (0.88) | 0.39 | 1 (2.22) | 1 (0.33) | 0.15 | 2.66 |
| Rotator cuff muscle injury | 4 (0.74) | 4 (0.62) | 0.27 | 4 (4.94) | 4 (1.18) | 0.51 | 0 (0) | 0 (0) | 0.00 | — |
| Shoulder soft tissue trauma | 1 (0.19) | 1 (0.16) | 0.07 | 0 (0) | 0 (0) | 0.00 | 1 (2.22) | 1 (0.33) | 0.15 | — |
| No diagnosis provided | 26 (4.81) | 26 (4.06) | 1.77 | 11 (13.58) | 11 (3.24) | 1.42 | 15 (33.33) | 15 (4.98) | 2.18 | 0.65 |
| Total | 126 (23.33) | 101 (15.76) | 6.89 | 81 (100) | 65 (19.12) | 8.36 | 45 (100) | 36 (11.96) | 5.23 | 1.6 |
Data are reported as n (%) unless otherwise indicated.
Relative risk, female vs male. The dashes indicate instances where either 0 females and/or 0 males were affected, which would make the RR a nonnatural number.
Statistical significance (P < .05).
Concussion Characteristics Observed Among Athletes in This Study
| Overall (N = 641) | Female Athletes (n = 340) | Male Athletes (n = 301) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Events | Athletes Affected | Estimated Athlete Risk/y, % | Events | Athletes Affected | Estimated Athlete Risk/y, % | Events | Athletes Affected | Estimated Athlete Risk/y, % | RR | |
| In-season | ||||||||||
| Competition | 4 (6.9) | 4 (0.62) | 0.27 | 4 (9.3) | 4 (1.18) | 0.51 | 0 (0) | 0 (0) | 0.00 | — |
| N/A | 8 (13.79) | 7 (1.09) | 0.48 | 6 (13.95) | 5 (1.47) | 0.64 | 2 (13.33) | 2 (0.66) | 0.29 | 2.21 |
| Non–sport related team activity | 5 (8.62) | 5 (0.78) | 0.34 | 4 (9.3) | 4 (1.18) | 0.51 | 1 (6.67) | 1 (0.33) | 0.15 | 3.54 |
| Practice | 19 (32.76) | 19 (2.96) | 1.30 | 15 (34.88) | 15 (4.41) | 1.93 | 4 (26.67) | 4 (1.33) | 0.58 | 3.32 |
| Weight room | 3 (5.17) | 3 (0.47) | 0.20 | 1 (2.33) | 1 (0.29) | 0.13 | 2 (13.33) | 2 (0.66) | 0.29 | 0.44 |
| Off-season | ||||||||||
| Competition | 0 (0) | 0 (0) | 0.00 | 0 (0) | 0 (0) | 0.00 | 0 (0) | 0 (0) | 0.00 | — |
| N/A | 9 (15.52) | 9 (1.4) | 0.61 | 7 (16.28) | 7 (2.06) | 0.90 | 2 (13.33) | 2 (0.66) | 0.29 | 3.1 |
| Non–sport related team activity | 4 (6.9) | 4 (0.62) | 0.27 | 3 (6.98) | 3 (0.88) | 0.39 | 1 (6.67) | 1 (0.33) | 0.15 | 2.66 |
| Practice | 6 (10.34) | 6 (0.94) | 0.41 | 3 (6.98) | 3 (0.88) | 0.39 | 3 (20) | 3 (1) | 0.44 | 0.89 |
| Weight room | 0 (0) | 0 (0) | 0.00 | 0 (0) | 0 (0) | 0.00 | 0 (0) | 0 (0) | 0.00 | — |
| Total | 58 (100) | 44 (6.86) | 3.00 | 43 (100) | 31 (9.12) | 3.99 | 15 (100) | 13 (4.32) | 1.89 | 2.11 |
Data are reported as n (%) unless otherwise indicated.
Relative risk, female vs male. The dashes indicate instances where either 0 females and/or 0 males were affected, which would make the RR a nonnatural number.
Statistical significance (P < .05).